Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Nilemdo and Nustendi

April 7, 2020

Millendo Therapeutics discontinues development of livoletide for PWS

April 7, 2020

Opaganib approved for compassionate use in patients with COVID-19 in Italy

April 7, 2020

First patient dosed in phase I study of COM-902 in advanced malignancies

April 7, 2020

Glycoprotein negatively regulates adult neurogenesis

April 7, 2020

Ennaid begins development of ENU-200 for COVID-19 infection

April 7, 2020

GRASP55 plays a key physiological role in intestinal lipid uptake

April 7, 2020

Large-scale proteomic analysis unveils a shift in glutaminate fate involved in cancer progression

April 7, 2020

Head and neck cancer cachexia mouse model developed

April 7, 2020

The dose makes the poison -- timing, too

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.